First Page | Document Content | |
---|---|---|
Date: 2017-05-01 03:53:28 | Application of Natural Resources to Drug Discovery in Eisai Research and Development of Eribulin mesylate Katsuya Tagami, Eisai Co., Ltd. Eribuin mesylate is a first-in class, non-taxane microtubule dynamics inhibitor thAdd to Reading ListSource URL: apac-asia.comDownload Document from Source WebsiteFile Size: 53,67 KBShare Document on Facebook |